T. Rowe Price Associates’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33,732
| Closed | -$77K | – | 3030 |
|
|
2024
Q2 | $77K | Buy |
33,732
+15,977
| +90% | +$36.5K | ﹤0.01% | 2789 |
|
|
2024
Q1 | $77K | Hold |
17,755
| – | – | ﹤0.01% | 2821 |
|
|
2023
Q4 | $55K | Hold |
17,755
| – | – | ﹤0.01% | 2798 |
|
|
2023
Q3 | $26K | Hold |
17,755
| – | – | ﹤0.01% | 2836 |
|
|
2023
Q2 | $45K | Hold |
17,755
| – | – | ﹤0.01% | 2810 |
|
|
2023
Q1 | $48K | Sell |
17,755
-29,639
| -63% | -$80.1K | ﹤0.01% | 2796 |
|
|
2022
Q4 | $257K | Sell |
47,394
-371
| -0.8% | -$2.01K | ﹤0.01% | 2436 |
|
|
2022
Q3 | $597K | Hold |
47,765
| – | – | ﹤0.01% | 2034 |
|
|
2022
Q2 | $236K | Sell |
47,765
-127,460
| -73% | -$630K | ﹤0.01% | 2528 |
|
|
2022
Q1 | $1.33M | Sell |
175,225
-659,202
| -79% | -$5.01M | ﹤0.01% | 1854 |
|
|
2021
Q4 | $8.52M | Buy |
834,427
+10,685
| +1% | +$109K | ﹤0.01% | 1426 |
|
|
2021
Q3 | $11.1M | Sell |
823,742
-3,847
| -0.5% | -$51.6K | ﹤0.01% | 1409 |
|
|
2021
Q2 | $18.2M | Sell |
827,589
-771,259
| -48% | -$16.9M | ﹤0.01% | 1319 |
|
|
2021
Q1 | $38.5M | Buy |
1,598,848
+47,938
| +3% | +$1.15M | ﹤0.01% | 1093 |
|
|
2020
Q4 | $27.9M | Buy |
1,550,910
+55,891
| +4% | +$1.01M | ﹤0.01% | 1126 |
|
|
2020
Q3 | $17.3M | Sell |
1,495,019
-82,177
| -5% | -$949K | ﹤0.01% | 1184 |
|
|
2020
Q2 | $38.3M | Buy |
1,577,196
+85,752
| +6% | +$2.08M | ﹤0.01% | 932 |
|
|
2020
Q1 | $16.4M | Sell |
1,491,444
-308,740
| -17% | -$3.4M | ﹤0.01% | 1124 |
|
|
2019
Q4 | $47.6M | Sell |
1,800,184
-21,411
| -1% | -$566K | 0.01% | 928 |
|
|
2019
Q3 | $41.5M | Buy |
1,821,595
+396,986
| +28% | +$9.04M | 0.01% | 931 |
|
|
2019
Q2 | $43.7M | Sell |
1,424,609
-65,558
| -4% | -$2.01M | 0.01% | 929 |
|
|
2019
Q1 | $24.7M | Sell |
1,490,167
-209,032
| -12% | -$3.47M | ﹤0.01% | 1104 |
|
|
2018
Q4 | $32.5M | Sell |
1,699,199
-242,213
| -12% | -$4.64M | 0.01% | 977 |
|
|
2018
Q3 | $102M | Buy |
1,941,412
+548,214
| +39% | +$28.7M | 0.01% | 668 |
|
|
2018
Q2 | $60.5M | Buy |
1,393,198
+277,930
| +25% | +$12.1M | 0.01% | 815 |
|
|
2018
Q1 | $41.3M | Buy |
+1,115,268
| New | +$41.3M | 0.01% | 939 |
|